1-7 of 7
lung cancer stage iv
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Primary Ambulatory Thromboprophylaxis (PATP) with Low-Molecular Weight Heparins (LMWHs) on Survival in Patients with Locally Advanced or Metastatic Lung Cancer (LC) Receiving Chemotherapy

Kyaw Zin Thein, MDMBBS, Lukman Tijani, MD, Thein H. Oo, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3466.
https://doi.org/10.1182/blood-2019-128561
Published: 2019
Journal Articles

Updated Meta-Analysis of Randomized Controlled Trials on Primary Ambulatory Thromboprophylaxis (PATP) in Patients with Locally Advanced or Metastatic Lung Cancer Receiving Chemotherapy

Kyaw Zin Thein, MDMBBS, Lukman Tijani, MD, Thein H. Oo, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2435.
https://doi.org/10.1182/blood-2019-123144
Published: 2019
Journal Articles

A Pilot Study of Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy with Ex Vivo Generated Polyomavirus-Specific T-Cells

Irene Cortese, Austin John Barrett, David F. Stroncek, Steven Highfill, PhD, Erin Beck, Frances Andrada, Joan Ohayon, Jennifer Dwyer, Matthew Schindler, Georg Aue, Daniel Reich, Avindra Nath, Pawel Muranski, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4535.
https://doi.org/10.1182/blood-2018-99-119832
Published: 2018
Journal Articles

Vaccination with a New Generation of Fast Dendritic Cells Transfected with mRNA from hTERT, Survivin and Autologous Tumor Mount Strong Immune Responses and Prolong Survival

Iris Bigalke, MD, Kirsti Honnashagen, Marianne Lundby, Julitta Kasten, Else Marit Suso Inderberg, PhD, Lisbeth Skoge, Stein Saboe-Larssen, PhD, Dolores J Schendel, PhD, Gunnar Kvalheim, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2440.
https://doi.org/10.1182/blood.V124.21.2440.2440
Published: 2014
Journal Articles

Risk of Second Primary Malignancies in Patients with AL Amyloidosis Treated with Lenalidomide

Vaishali Sanchorawala, MD, Anthony C Shelton, RN, Gheorghe Doros, PhD, David C Seldin, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1873.
https://doi.org/10.1182/blood.V120.21.1873.1873
Published: 2012
Journal Articles

Frontline Combined Chemoimmunotherapy with Fludarabine, Cyclophosphamide, Alemtuzumab and Rituximab (CFAR) in High-Risk Chronic Lymphocytic Leukemia.

Sameer A Parikh, MD, Michael Keating, MD, Susan O'Brien, Alessandra Ferrajoli, Stefan Faderl, MD, Charles Koller, MD, Zeev Estrov, Susan Lerner, M.S., RHIA, William G. Wierda, M.D., Ph.D
Journal: Blood
Blood (2009) 114 (22): 208.
https://doi.org/10.1182/blood.V114.22.208.208
Published: 2009
Journal Articles

Nonmyeloablative Conditioning and Hematopoietic Cell Transplantation (HCT) from HLA-Matched Related or Unrelated Donors for Chemotherapy-Refractory Chronic Lymphocytic Leukemia (CLL).

Mohamed Sorror, MD, MSc, Michael Maris, MD, Barry Storer, PhD, Brenda Sandmaier, MD, Monic Stuart, MD, Ute Hegenbart, MD, Edward Agura, MD, Thomas Chauncey, MD, Jose Leis, MD, PhD, Michael Pulsipher, MD, Peter McSweeney, MD, Jerry Radich, MD, James Wade, MD, Benedetto Bruno, MD, Amelia Langston, MD, Dietger Niederwieser, MD, Karl Blume, MD, Rainer Storb, MD, David Maloney, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2323.
https://doi.org/10.1182/blood.V104.11.2323.2323
Published: 2004